Effect of simulated intestinal fluid on drug permeability estimation across Caco-2 monolayers
Introduction
The transepithelial transport of compounds is an important characteristic, commonly assessed during the evaluation and selection of potential drug candidates. The Caco-2 cell culture model was introduced in the early 1990s and has become a widely used tool for the determination of the intestinal transport characteristics of compounds (Hidalgo et al., 1989, Hilgers et al., 1990, LeCluyse and Sutton, 1997, Gan and Thakker, 1997). Several reports have demonstrated the possibility to predict the oral absorption of drugs in man based on their permeability observed in Caco-2 monolayers (Artursson and Karlsson, 1991, Artursson et al., 2001). Within the framework of the Biopharmaceutic Classification System (BCS), the rate of mass transfer of a compound across the Caco-2 monolayer can even be considered to allow a waiver for in vivo bioequivalence studies (Yu et al., 2002). However, many discrepancies in culturing and experimental conditions can be identified in the literature related to Caco-2 maintenance and experiments.
For the realization of permeability and transport studies on the Caco-2 cell culture model, classic buffered salt solutions are commonly used (e.g. Hanks’ balanced salt solution (HBSS) buffered with HEPES (10 mM) at pH 7.4 and supplemented with glucose). Nevertheless, many shortcomings are associated with the use of such saline buffers for Caco-2 experiments, including the limited solubility of highly lipophilic drugs, the adsorption and/or non-specific binding to the device surfaces or (in)to the cells and the poor physiological relevance of the media used. To overcome these issues, several categories of media (for the apical and basolateral compartment), including plain salt solutions composed of inorganic salts and glucose, culture medium and solvents mimicking intestinal fluid have been proposed and have recently been reviewed (Ingels and Augustijns, 2003).
We investigated the possibility of using fasted state simulated intestinal fluid (FaSSIF) as apical solvent for Caco-2 experiments. FaSSIF has originally been introduced by the group of Professor Dressman in 1998 as dissolution medium to simulate the in vivo dissolution behavior of compounds (Galia et al., 1998, Dressman et al., 1998, Dressman and Reppas, 2000). The composition of FaSSIF is shown in Table 1. It has previously been shown that FaSSIF buffer was compatible with the Caco-2 cell monolayer for at least 2 h. The transport of different model compounds (i.e. theophylline (passive diffusion), phenylalanine (active transport)) and the activity of the brush border enzyme aminopeptidase were similar when using classic TM and FaSSIF. However, a concentration-dependent P-gp inhibitory activity of sodium taurocholate (NaTC) (present in FaSSIF) when assessing cyclosporin A (CsA) transport was demonstrated (Ingels et al., 2002a).
The aim of the present study was to evaluate the impact of FaSSIF as potential biorelevant medium on the permeability estimation and transport characteristics of drug compounds in the Caco-2 cell culture model.
Section snippets
Materials
Sodium taurocholate (NaTC) was purchased from Fluka (Bornem, Belgium). Phospholipon 90G was provided by Nattermann Phospholipid GmbH (Köln, Germany). Atenolol, digoxin, sulfasalazine, phenylalanine, progesterone, lidocaine, indomethacin, prazosin, theophylline, chlorothiazide, danazol, furosemide, verapamil, doxorubicin and propranolol were from Sigma (Bornem, Belgium). Talinolol was kindly provided by AWD Pharma GmbH & Co., Dresden, Germany. All solvents used for analysis were HPLC grade.
Bi-directional assays
Model compounds (Table 2) were evaluated for their bi-directional transport in the Caco-2 experimental set-up with FaSSIF as donor medium as compared to classic TM. The A-to-B and B-to-A Papp was calculated following Eq. (1) for all the compounds dissolved in either FaSSIF or TM (donor medium). The apparent permeability coefficients (cm/s) obtained for the A-to-B and B-to-A transport of the test compounds are summarized in Table 3.
The presence of FaSSIF as donor solvent did not influence the
Conclusions
In this paper, we evaluated the effect of using FaSSIF buffer as medium for performing Caco-2 experiments. Although the use of FaSSIF as compared to TM did not affect the global predictive value of the model, an impact was shown on (1) the permeation determination of actively transported drugs (including talinolol, digoxin, doxorubicin, sulfasalazine and furosemide), (2) on the solubility and permeation of the poorly water-soluble drug danazol and (3) on the recovery values of more lipophilic
Acknowledgements
This study was partly supported by grants from the ‘Fonds voor Wetenschappelijk Onderzoek’ (FWO), Flanders and from the ‘Onderzoeksfonds’ of the KULeuven, Belgium.
References (39)
- et al.
Correlation between oral drug absorption in humans and apparent drug permeability coefficients in human epithelial (Caco-2) cells
Biochem. Biophys. Res. Commun.
(1991) - et al.
Caco-2 monolayers in experimental and theoretical predictions of drug transport
Adv. Drug Del. Rev.
(2001) - et al.
Drug absorption of prodrug esters using the Caco-2 model: evaluation of ester hydrolysis and transepithelial transport
Int. J. Pharm.
(1998) - et al.
Cell cultures as tools in biopharmacy
Eur. J. Pharm. Sci.
(2000) - et al.
In vitro–in vivo correlations for lipophilic, poorly water-soluble drugs
Eur. J. Pharm. Sci.
(2000) - et al.
Bioavailibility of danazol-hydroxypropyl-β-cyclodextrin complex by different routes of administration
Int. J. Pharm.
(1996) - et al.
Applications of the Caco-2 model in the design and development of orally active drugs: elucidation of biochemical and physical barriers posed by the intestinal epithelium
Adv. Drug Del. Rev.
(1997) - et al.
Characterization of human colon carcinoma cell line (Caco-2) as a model system for intestinal epithelial permeability
Gastroenterology
(1989) - et al.
Simulated intestinal fluid as transport medium in the Caco-2 cell culture model
Int. J. Pharm.
(2002) - et al.
MDCK (Madin-Darby Canine Kidney) cells: a tool for membrane permeability screening
J. Pharm. Sci.
(1999)
Effect of the breast-cancer resistance protein on atypical multidrug resistance
The Lancet Onc.
In vitro models for selection of development candidates. Permeability studies to define mechanisms of absorption enhancement
Adv. Drug Del. Rev.
Comparison between active and passive drug transport in human intestinal epithelial (Caco-2) cells in vitro and human jejunum in vivo
Int. J. Pharm.
Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings
Adv. Drug Del. Rev.
Immobilized liposome chromatography to study drug-membrane interactions. Correlation with drug absorption in humans
J. Chrom. A
Modern bioavailibility, bioequivalence and biopharmaceutics classification system. New scientific approaches to intestinal regulatory standards
Eur. J. Pharm. Sci.
Link between drug absorption solubility and permeability measurements in Caco-2 cells
J. Pharm. Sci.
Optimized conditions for MDCK permeability and turbidimetric solubility studies using compounds representative of BCS classes I–IV
J. Pharm. Sci.
Enhanced transport of a novel anti-HIV agent cosalane and its congeneres across human intestinal epithelial (Caco-2) cell monolayers
Int. J. Pharm.
Cited by (135)
Increased bioavailability of a P-gp substrate: Co-release of etoposide and zosuquidar from amorphous solid dispersions
2023, International Journal of PharmaceuticsOrganic microelectrode arrays for bioelectronic applications
2023, Materials Science and Engineering R: ReportsInteraction of polymers with bile salts – Impact on solubilisation and absorption of poorly water-soluble drugs
2023, Colloids and Surfaces B: Biointerfaces‘Stirred not Shaken!’ Comparing Agitation Methods for Permeability Studies Using a Novel Type of 96-Well Sandwich-Plates
2022, Journal of Pharmaceutical SciencesInvestigating the Critical Variables of Azithromycin Oral Absorption Using In Vitro Tests and PBPK Modeling
2021, Journal of Pharmaceutical Sciences